- 32 Downloads
It is ironic that what is purchased and applied for the protection of one’s health might turn out to be injurious to it. Yet we see this occurring constantly in the phenomenon of iatrogenic disease. Sometimes in these cases licensed medications surprise us with adverse side effects. It is difficult to eliminate this possibility though thorough testing demanded by the licensing process limits its occurrence. Additionally, guidance is offered on the use of medications in relation to other medications already used by the patient, as a further protection against drug-induced disease.
Cosmetic products such as sunscreens are not so well controlled in most countries. In some they are covered by common legislation such as the Federal Food, Drug and Cosmetic Act in the USA. There the Food and Drug Administration (FDA) is responsible for licensing such applications. Yet even that protection is flawed in the use of products containing nanoparticles of known safe substances such as Zinc Oxide. It...
KeywordsThalidomide Zinc Oxide Adverse Side Effect Cosmetic Product Animal Organ
- Brown, D. 2002. Nano Litterbugs? Experts see Potential Pollution Problems. http://smalltimes.com/print_doc.cfm?doc_id=3266. Accessed December 11, 2006, site now discontinued.
- Dunford, R., A. Salinaro, L. Cai, N. Serpone, S. Horikoshi, H. Hidaka, and J. Knowland. 1997. Chemical oxidation and DNA damage caused by inorganic sunscreen ingredients. FEBS Letters 418(1–2) 24: 87–90.Google Scholar
- SCCNFP/0649/03. SCCNFP: Brussels. http://ec.europa.eu/health/ph_risk/committees/sccp/documents/out222_en.pdf. Accessed 4 November 2008.
- The Action Group on Erosion. Technology and Concentration (The ETC Group), 2002. No small matter! Nanotech particles penetrate living cells and accumulate in animal organs. http://online.sfsu.edu/~rone/Nanotech/nosmallmatter.html. Accessed December 11 2006.
- The Royal Society. 2004. Nanoscience and nanotechnologies: Opportunities and uncertainties. http://www.nanotec.org.uk/finalReport.htm. Accessed 4 November 2008. SCCNFP. Opinion concerning zinc oxide (COLIPA n° S 76).